Takara Bio (FRA:TF2) Short Interest


FRA:TF2 Takara Bio Inc FRA:TF2
71 GF Score
Price €5.95
GF Value €4.45
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Takara Bio Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:TF2 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Takara Bio's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takara Bio Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Takara Bio's Short Interest distribution charts can be found below:

* The bar in red indicates where Takara Bio's Short Interest falls into.


FRA:TF2
71GF Score
Takara Bio Inc FRA:TF2
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Takara Bio (FRA:TF2) Overvalued in 2026?

Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued. The current stock price of €5.95 is trading 33.7% above its estimated GF Value™ of €4.45. GuruFocus considers Takara Bio to be Significantly Overvalued.

Key valuation signals for FRA:TF2:

  • Short Interest:
  • GF Value™: €4.45 vs. price of €5.95 (33.7% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the FRA:TF2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takara Bio Business Description

Other Exchanges 4974:Japan
Address Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
71GF Score

Get the complete analysis for FRA:TF2

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.95
Price
€4.45
GF Value